To hear about similar clinical trials, please enter your email below
Trial Title:
Role of PET/CT in Peritoneal Deposits Assessment
NCT ID:
NCT06137417
Condition:
Peritoneal Metastases
Conditions: Official terms:
Neoplasm Metastasis
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Device
Intervention name:
PET/CT
Description:
• Suspected patients known to have a primary malignant tumour, patients with metastasis
of unknown primary and had incidental peritoneal lesions.
Summary:
• Suspected patients known to have a primary malignant tumour, patients with metastasis
of unknown primary and had incidental peritoneal lesions and will do PET/CT for
assessment of peritoneal deposits
Detailed description:
Suspected patients known to have a primary malignant tumour, patients with metastasis of
unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment
of peritoneal deposits. we will find its diagnostic role.
Criteria for eligibility:
Study pop:
Suspected patients known to have a primary malignant tumour, patients with metastasis of
unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment
of peritoneal deposits
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- • Suspected patients known to have a primary malignant tumour, patients with
metastasis of unknown primary and had incidental peritoneal lesions.
Exclusion Criteria:
- • Patients unable to sit calm without movement during imaging.
- Severely ill patients.
- Patients unable to sleep in a fixed position for 20 minutes.
- Pregnancy
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Start date:
January 1, 2024
Completion date:
March 15, 2026
Lead sponsor:
Agency:
Aya Khaled Mahmoud
Agency class:
Other
Source:
Assiut University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06137417
